0001209191-19-034780.txt : 20190605 0001209191-19-034780.hdr.sgml : 20190605 20190605165406 ACCESSION NUMBER: 0001209191-19-034780 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190603 FILED AS OF DATE: 20190605 DATE AS OF CHANGE: 20190605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Holden Stuart CENTRAL INDEX KEY: 0001763999 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 19880414 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA LTD. STREET 2: 9 HA'TA'ASIYA STREET CITY: RA'ANANA STATE: L3 ZIP: 4365007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-03 0 0001668243 UroGen Pharma Ltd. URGN 0001763999 Holden Stuart C/O UROGEN PHARMA LTD. 499 PARK AVENUE NEW YORK CITY NY 10022 1 0 0 0 Stock Option (Right to Buy) 34.83 2019-06-03 4 A 0 10000 0.00 A 2019-06-02 Ordinary Shares 10000 10000 D The shares underlying the stock option will vest in equal quarterly installments over a period of two years. /s/ Peter Pfreundschuh, Attorney-in-Fact 2019-06-05